These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1335078)
1. O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay. Klein P; Nelson WL J Med Chem; 1992 Nov; 35(24):4589-94. PubMed ID: 1335078 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol. Nelson TD; Davis RD; Nelson WL J Med Chem; 1994 Dec; 37(25):4270-7. PubMed ID: 7996538 [TBL] [Abstract][Full Text] [Related]
3. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210 [No Abstract] [Full Text] [Related]
4. Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol. Davis RD; Nelson WL J Med Chem; 1995 Feb; 38(3):570-9. PubMed ID: 7853350 [TBL] [Abstract][Full Text] [Related]
5. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands. Fang X; Larson DL; Portoghese PS J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
7. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors. Gao P; Larson DL; Portoghese PS J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249 [TBL] [Abstract][Full Text] [Related]
9. Syntheses and receptor-binding studies of derivatives of the opioid antagonist naltrexone. Uwai K; Uchiyama H; Sakurada S; Kabuto C; Takeshita M Bioorg Med Chem; 2004 Jan; 12(2):417-21. PubMed ID: 14723960 [TBL] [Abstract][Full Text] [Related]
10. Electrophilic opioid ligands. Oxygen tethered alpha-methylene-gamma-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6 beta-naltrexol. Dasher WE; Klein P; Nelson WL J Med Chem; 1992 Jun; 35(13):2374-84. PubMed ID: 1320121 [TBL] [Abstract][Full Text] [Related]
11. Kinetic evidence for differential agonist and antagonist binding to bovine hippocampal synaptic membrane opioid receptors. Scheibe SD; Bennett DB; Spain JW; Roth BL; Coscia CJ J Biol Chem; 1984 Nov; 259(21):13298-303. PubMed ID: 6092373 [TBL] [Abstract][Full Text] [Related]
20. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist. Frances B; Puget A; Moisand C; Meunier JC Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]